Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 8.50
+0.40 (4.94%)
At close: Dec 5, 2025
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €63.96 million as of December 5, 2025. Its market cap has increased by 289.06% in one year.
Market Cap
63.96M
Enterprise Value
62.09M
Revenue
8.09M
Ranking
n/a
PE Ratio
32.76
Stock Price
€8.50
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 63.96M, an increase of 316.14%. That is a compound annual growth rate of 46.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 63.96M | 292.66% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.30B |
| Laboratorios Farmaceuticos Rovi | 3.06B |
| Almirall | 2.77B |
| Faes Farma | 1.49B |
| Pharma Mar | 1.27B |
| Clínica Baviera | 752.57M |
| Oryzon Genomics | 256.27M |
| Prim, S.A. | 235.67M |